Why Attend

Agenda
Location & CLE

The Food and Drug Law Institute (FDLI) will present academic scholarship at the 2022 Food and Drug Law Journal Symposium exploring the relationships between FDA and other domestic regulators. This Symposium will offer wide-ranging discussion, among scholars and practitioners, of the actual and the possible, the problematic and the productive, what has been learned, what should be studied, what might be changed, practical impediments and legal obstacles, cautions and concerns, and what the future might hold.

The Food and Drug Law Journal Symposium will encourage thoughtful legal scholarship on topics that may be historical, descriptive, empirical, theoretical, or normative, as the subject dictates. Papers to be presented will consider domestic regulators, or combination of them, from the CDC, CMS, and other sister agencies within HHS, to the Patent and Trademark Office (PTO), FTC, DoD, SEC, EPA, and state regulators.

For a full list of topics, please visit our agenda webpage here.

Call for Abstracts

The Call for Abstracts closed on June 27, 2022, and authors of selected papers will be notified by July 8, 2022. Draft articles must be submitted by October 17. Following the Symposium on November 3–4, 2022, finalized papers will be considered for publication in a dedicated issue of the Food and Drug Law Journal. Thank you to everyone who submitted a paper!

Please contact Paige Samson with any questions.

Article Submissions:

The Food and Drug Law Journal (FDLJ) is the publication sponsor for this Symposium and reserves a right of first refusal to publish accepted papers, subject to the editorial review process. All final papers should be under 25,000 words in length, double-spaced, and in Times New Roman font. FDLJ requires footnotes that conform with the 21st edition of The Bluebook: A Uniform System of Citation. Additional author guidelines are available here. Questions regarding submission requirements may be directed to [email protected].

Register

 

Industry & Firms

FREE
  • $199 for nonmembers

Non-Profit

FREE
  • $49 for nonmembers

Government

FREE
  • $49 for nonmembers

Academic

FREE
  • $49 for nonmembers

Student

FREE
  • full-time students only

Sponsorship Opportunities

Sponsorship opportunities are available. Please let us know if you would like more information.

 

Planning Committee

Daren Bakst, The Heritage Foundation
Marie Boyd, University of South Carolina
Christine P. Bump, Penn Avenue Law & Policy
Jonathan M. Cohen, K&L Gates LLP
Bridget C.E. Dooling, George Washington University
Jamie W. Gamerman, FDA–CDER
Lewis A. Grossman, American University
John F. Johnson III, Shook, Hardy & Bacon LLP
Sara Koblitz, Hyman Phelps & McNamara
Erika Lietzan, University of Missouri-Columbia School of Law and Chair, Food and Drug Law Journal Editorial Advisory Board
Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
Adam Muchmore, Penn State Law
James O’Reilly, University of Cincinnati
Daniel Orr, Thomson Reuters
Tina Papagiannopoulos, Foley Hoag LLP
Tyler Scandalios, Arnold & Porter LLP